Chosa (XSAT: CHOSA)

Last close As at 05/08/2026

SEK0.77

0.01 (1.32%)

Market capitalisation

SEK71m

Chosa Oncology (previously RhoVac) is a Danish biotech focused on the development of iCIP, a technology consisting of a cisplatin drug response predictor and a liposomal formulation of conventional cisplatin. iCIP has demonstrated encouraging clinical proof of concept from a Phase IIb study in breast cancer patients and Chosa is now looking for strategic partnerships to progress clinical development of the technology.

Latest Insights

View More

Healthcare | edison tv

CHOSA Oncology – executive interview

Healthcare | Update

Chosa Oncology — Making headway in precision oncology

Healthcare | Update

RhoVac — On the home straight

Healthcare | Outlook

RhoVac — Phase IIb BRaVac study results in H122

Market Data

Share Price SEK0.77
Market Cap SEK71m
52-Week High SEK2.20
52-Week Low SEK0.53
% Change 1M (3.8)
% Change 6M (3.4)
% Change 12M 40.9
Ave. Daily Volume 1yr 72,355

Sector

Healthcare

Equity Analyst

Key Management

  • Claus Frisenberg Pedersen

    CFO

  • Neil Goldsmith

    Chairman

  • Peter Buhl Jensen

    CEO

Share Price Chart

Research

Outlook

Healthcare

RhoVac — Phase IIb BRaVac study results in H122

Update

Healthcare

RhoVac — COVID-19 vaccines versus RV001

Update

Healthcare

RhoVac — Fast Track designation granted by FDA

Update

Healthcare

RhoVac — Limited impact from COVID-19 pandemic

Update

Healthcare

RhoVac — Phase IIb study progressing to plan

Update

Healthcare

RhoVac — Phase IIb BRaVac study enrolling patients

edison tv

Healthcare

Executive interview – RhoVac

Thematics

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.